Andrew Read

Senior Vice President for Research; Evan Pugh Professor of Biology and Entomology; Eberly Professor of Biotechnology

Andrew Read

Research Summary

The ecology and evolutionary genetics of infectious disease.

Huck Affiliations

Links

Publication Tags

These publication tags are generated from the output of this researcher. Click any tag below to view other Huck researchers working on the same topic.

Pharmaceutical Preparations Resistance Vaccines Virulence Viruses Therapeutics Pathogens Drug Resistance Daptomycin Vaccination Chemotherapy Aquaculture Rabbits Wastewater Myxoma Virus Drug Therapy Drugs Anti Bacterial Agents Population Antibiotics Health Drug Antibiotic Resistance Resistance Management Enterococcus Faecium

Most Recent Publications

Combination antimicrobial therapy to manage resistance

Robert J. Woods, Andrew F. Read, 2023, Evolution, Medicine and Public Health on p. 185-186

The evolution of antibiotic resistance in an incurable and ultimately fatal infection: A retrospective case study

Robert J. Woods, Camilo Barbosa, Laura Koepping, Juan A. Raygoza, Michael Mwangi, Andrew F. Read, 2023, Evolution, Medicine and Public Health on p. 163-173

Divergent Evolutionary Pathways of Myxoma Virus in Australia: Virulence Phenotypes in Susceptible and Partially Resistant Rabbits Indicate Possible Selection for Transmissibility

Peter J. Kerr, Isabella M. Cattadori, Derek Sim, June Liu, Edward C. Holmes, Andrew F. Read, 2022, Journal of Virology

Ion Exchange Biomaterials to Capture Daptomycin and Prevent Resistance Evolution in Off-Target Bacterial Populations

Shang Lin Yeh, Naveen Narasimhalu, Landon G. Vom Steeg, Joy Muthami, Sean Leconey, Zeming He, Mica Pitcher, Harrison Cassady, Valerie J. Morley, Sung Hyun Cho, Carol Bator, Roya Koshani, Robert J. Woods, Michael Hickner, Andrew F. Read, Amir Sheikhi, 2022, ACS applied materials & interfaces on p. 42864-42875

Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania

Kathryn Hayden, Matthew Jones, Kyle Elkin, Michael Shreve, William Clees, Shirley Clark, Michael L. Mashtare, Tamie Veith, Hershel Elliott, J Watson, Justin Silverman, Thomas L. Richard, Andrew F. Read, Heather E. Preisendanz, 2022, Journal of Environmental Quality on p. 1066-1082

Pathogen evolution during vaccination campaigns

Troy Day, David Kennedy, Andrew F. Read, Sylvain Gandon, 2022, PLoS Biology on p. e3001804

A longitudinal study of the impact of university student return to campus on the SARS-CoV-2 seroprevalence among the community members

Callum R.K. Arnold, Sreenidhi Srinivasan, Sophie Rodriguez, Natalie Rydzak, Catherine M. Herzog, Abhinay Gontu, Nita Bharti, Meg Small, Connie J. Rogers, Margeaux M. Schade, Suresh V. Kuchipudi, Vivek Kapur, Andrew F. Read, Matthew J. Ferrari, 2022, Scientific Reports on p. 8586

An orally administered drug prevents selection for antibiotic-resistant bacteria in the gut during daptomycin therapy

Valerie J. Morley, Derek G. Sim, Aline Penkevich, Robert J. Woods, Andrew F. Read, 2022, Evolution, Medicine and Public Health on p. 439-446

The economics of managing evolution

Troy Day, David A. Kennedy, Andrew F. Read, David McAdams, 2021, PLoS Biology

Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium

Clare L. Kinnear, Elsa Hansen, Valerie J. Morley, Kevin C. Tracy, Meghan Forstchen, Andrew F. Read, Robert J. Woods, 2020, PLoS Biology

Most-Cited Papers

Imperfect vaccination can enhance the transmission of highly virulent pathogens

Andrew F. Read, Susan J. Baigent, Claire Powers, Lydia B. Kgosana, Luke Blackwell, Lorraine P. Smith, David A. Kennedy, Stephen W. Walkden-Brown, Venugopal K. Nair, 2015, PLoS Biology on p. e1002198

Antibiotic resistance management

Andrew F. Read, Robert J. Woods, 2014, Evolution, Medicine and Public Health on p. 147

Malaria-induced changes in host odors enhance mosquito attraction

Consuelo M. De Moraes, Nina M. Stanczyk, Heike S. Betz, Hannier Pulido, Derek G. Sim, Andrew F. Read, Mark C. Mescher, 2014, Proceedings of the National Academy of Sciences of the United States of America on p. 11079-11084

Antibiotic Resistance: A Primer and Call to Action

Rachel A. Smith, Nkuchia M. M’ikanatha, Andrew F. Read, 2015, Health Communication on p. 309-314

Why does drug resistance readily evolve but vaccine resistance does not?

David A. Kennedy, Andrew F. Read, 2017, Proceedings of the Royal Society B: Biological Sciences

Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?

Troy Day, Andrew F. Read, 2016, PLoS Computational Biology

Potential drivers of virulence evolution in aquaculture

David A. Kennedy, Gael Kurath, Ilana L. Brito, Maureen K. Purcell, Andrew F. Read, James R. Winton, Andrew R. Wargo, 2016, Evolutionary Applications on p. 344-354

The importance of temperature fluctuations in understanding mosquito population dynamics and malaria risk

Lindsay M. Beck-Johnson, William A. Nelson, Krijn P. Paaijmans, Andrewf Read, Matthew B. Thomas, Ottar N. Bjørnstad, 2017, Royal Society Open Science

How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient

Elsa Hansen, Robert J. Woods, Andrew F. Read, 2017, PLoS Biology

Myxoma virus and the leporipoxviruses: An evolutionary paradigm

Peter Kerr, June Liu, Isabella Cattadori, Elodie Ghedin, Andrew F. Read, E Holmes, 2015, Viruses on p. 1020-1061

News Articles Featuring Andrew Read

Apr 25, 2024

$20M NSF grant to support center to study how complex biological processes arise

A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at Penn State.

Full Article

Apr 08, 2024

Podcast sheds light on the evolution of disease-causing pathogens

As the ever-growing number of Covid variants has made clear to the global public in recent years, disease-causing viruses can evolve incredibly fast. The same holds true for bacteria that cause many infectious diseases. Andrew Read was interviewed about his career as a prominent researcher in this field.

Full Article

Mar 27, 2024

Andrew Read named senior vice president for research

 Andrew Read, the former director of the Huck Institutes of the Life Sciences and a faculty member in the departments of biology and entomology, has been selected to serve as Penn State’s senior vice president for research.

Full Article

Feb 15, 2024

Committee advances plan to rename Chemistry Building as 'Benkovic Building'

The Chemistry Building at the University Park campus will be renamed in honor of the careerlong scholarly impact of Stephen Benkovic, Atherton Professor of Chemistry

Full Article

Jan 25, 2024

Penn State, QIAGEN announce strategic partnership to advance microbiome sciences

Penn State, known for innovations in interdisciplinary research, and QIAGEN LLC, a leader in sample-to-insight solutions, have signed a memorandum of understanding (MOU) to foster advancements in microbiome sciences

Full Article

Sep 28, 2023

Penn State rises in THE World University Rankings; places 20th among US publics

Penn State ranked 20th for U.S. public universities, and 42nd in the nation overall, in the 2024 Times Higher Education World University Rankings.

Full Article

Sep 15, 2023

Seed grants fund research collaborations with minority-serving institutions

The first awardees of Penn State’s new Inter-Institutional Partnerships for Diversifying Research (IDPR) initiative have been selected, comprising a total of 16 collaborative projects that connect Penn State researchers with colleagues from minority-serving institutions (MSIs).

Full Article

Sep 07, 2023

Covid Continues to Rise, but Experts Remain Optimistic

Covid-19 numbers continue to rise and evolve but experts are optimistic

Full Article

Aug 24, 2023

Douglas Wolfe named AVP for Research, director of strategic initiatives

Douglas E. Wolfe has been named the new associate vice president for Research, director of strategic initiatives (AVPR-SI) within the Office of the Senior Vice President for Research (OSVPR) at Penn State, effective Sept. 18.

Full Article

Jun 27, 2023

Penn State Trustees Hear Plans to Boost Research Enterprise

Penn State achieved a record $1.03 billion in research expenditures in FY22 and is poised for continued growth as one of the nation's top research institutions, Lora G. Weiss, senior vice president for research, told the Board of Trustees' Committee on Academic Affairs, Research and Student Life on June 15.

Full Article